The subject of the order is divided into 3 lots;
- Part I (package No. 1) - medicines used for infections;
- Part II (package No. 2) - respiratory system, drugs and medical devices used in eye and ear diseases;
- Part III (package No. 3) - specialist dressings used in wound care.
A detailed description of the quantity of the subject of the order is provided in Annexes 1 to 3 to this specification for each part respectively.
The subject of this order are successive deliveries to Prison No. 2 in Łódź of medicinal products defined in the Common Procurement Vocabulary (CPV) with code number 33600000 as "pharmaceutical products", medical devices and foodstuffs for particular nutritional uses in the estimated quantities and in the assortment indicated in tabular statements constituting attachments from numbers 1 to 3 to the specification of essential terms of the contract. The Purchaser declares that whenever the Purchaser used the trade names of medicines, medical devices and foodstuffs for particular nutritional uses, he did so in accordance with art. 29 paragraph 3 of the Public Procurement Law Act solely for the purpose of precisely specifying the active substance or composition of active substances (or intended use) contained in the ordered medicines and foodstuffs for particular nutritional uses, or specifying medical devices. The use of these names means only that the Employer requests the offer of products containing these active substances or compositions of active substances as the products whose names have been used and allows offering both the same products and equivalent products, which should be understood as identical in terms of composition of active substances, intended use and effect as well as method of administration. In the case of medicinal products administered by the oral route, it may be allowed to replace, for example, dragee tablets, dragee capsules, tablets for coated tablets, ampoules for vials, etc., except for the situations described in point 3.2.7. SIWZ The Purchaser does not allow the exchange of soluble tablets for ordinary ones. It also does not allow substitution in terms of duration of action, preparations with prolonged action cannot be replaced with those with unmodified release time of the active substance. The Employer recognizes that the prolonged-action tablets correspond to modified-release tablets. The same principles apply accordingly to medical devices.
The subject of this order are successive deliveries to Prison No. 2 in Łódź of medicinal products defined in the Common Procurement Vocabulary (CPV) with code number 33600000 as "pharmaceutical products", medical devices and foodstuffs for particular nutritional uses in the estimated quantities and in the assortment indicated in tabular statements constituting attachments from numbers 1 to 3 to the specification of essential terms of the contract. The Purchaser declares that whenever the Purchaser used the trade names of medicines, medical devices and foodstuffs for particular nutritional uses, he did so in accordance with art. 29 paragraph 3 of the Public Procurement Law Act solely for the purpose of precisely specifying the active substance or composition of active substances (or intended use) contained in the ordered medicines and foodstuffs for particular nutritional uses, or specifying medical devices. The use of these names means only that the Employer requests the offer of products containing these active substances or compositions of active substances as the products whose names have been used and allows offering both the same products and equivalent products, which should be understood as identical in terms of composition of active substances, intended use and effect as well as method of administration. In the case of medicinal products administered by the oral route, it may be allowed to replace, for example, dragee tablets, dragee capsules, tablets for coated tablets, ampoules for vials, etc., except for the situations described in point 3.2.7. SIWZ The Purchaser does not allow the exchange of soluble tablets for ordinary ones. It also does not allow substitution in terms of duration of action, preparations with prolonged action cannot be replaced with those with unmodified release time of the active substance. The Employer recognizes that the prolonged-action tablets correspond to modified-release tablets. The same principles apply accordingly to medical devices.
The subject of this order are successive deliveries to Prison No. 2 in Łódź of medicinal products defined in the Common Procurement Vocabulary (CPV) with code number 33600000 as "pharmaceutical products", medical devices and foodstuffs for particular nutritional uses in the estimated quantities and in the assortment indicated in tabular statements constituting attachments from numbers 1 to 3 to the specification of essential terms of the contract. The Purchaser declares that whenever the Purchaser used the trade names of medicines, medical devices and foodstuffs for particular nutritional uses, he did so in accordance with art. 29 paragraph 3 of the Public Procurement Law Act solely for the purpose of precisely specifying the active substance or composition of active substances (or intended use) contained in the ordered medicines and foodstuffs for particular nutritional uses, or specifying medical devices. The use of these names means only that the Employer requests the offer of products containing these active substances or compositions of active substances as the products whose names have been used and allows offering both the same products and equivalent products, which should be understood as identical in terms of composition of active substances, intended use and effect as well as method of administration. In the case of medicinal products administered by the oral route, it may be allowed to replace, for example, dragee tablets, dragee capsules, tablets for coated tablets, ampoules for vials, etc., except for the situations described in point 3.2.7. SIWZ The Purchaser does not allow the exchange of soluble tablets for ordinary ones. It also does not allow substitution in terms of duration of action, preparations with prolonged action cannot be replaced with those with unmodified release time of the active substance. The Employer recognizes that the prolonged-action tablets correspond to modified-release tablets. The same principles apply accordingly to medical devices.